The Dental Economist Show · 2026-08-20 · 46 min
What will separate the next generation of winning DSOs from the roll-up models of the past? In this episode of The Dental Economist Show, host Mike Huffaker speaks with Chris Moxon, Managing Director and Partner at Boston Consulting Group, about the future of the dental market, DSO consolidation, and the operational foundations required for sustainable growth. Chris shares BCG’s data-led perspective on why dentistry remains a compelling market: resilient underlying demand, a significant number of patients still outside the care system, and growing recognition of the connection between oral and overall health. He explains how preventative care, salivary diagnostics, and better patient communication can improve treatment acceptance while creating better outcomes. The conversation also explores the realities of consolidation. Chris explains why dental is unlikely to consolidate like pharmacy, why de novo growth depends on more than capital and real estate, and why strategic acquisitions need a clear clinical and operational rationale.
Other episodes covering the same guests and topics, from across The B2B Podcast Index.
Dr. Shilpi Priyadarshini on Building Clinical Systems That Help Dentists and Patients Win95 / 100
Stephen Thorne on Moving Dentistry From Sick Care to Preventive Healthcare84 / 100
Keith Miller on What Dentists Should Ask Before Partnering With a DSO88 / 100
Dykema DSO Conference Edition with Brian Colao48 / 100
Leslie Espinola on Why Most Dental Practices Fail for Business Reasons Not Clinical Ones73 / 100
